Chemoradiation Therapy as Definitive Treatment of Esophageal Cancer.
Definitive chemoradiation
Esophageal carcinoma
Immunotherapy
Multimodality therapy
Journal
The Surgical clinics of North America
ISSN: 1558-3171
Titre abrégé: Surg Clin North Am
Pays: United States
ID NLM: 0074243
Informations de publication
Date de publication:
Jun 2021
Jun 2021
Historique:
entrez:
28
5
2021
pubmed:
29
5
2021
medline:
8
6
2021
Statut:
ppublish
Résumé
Definitive chemoradiation therapy avoids the perioperative and long-term morbidity of esophagectomy and is the standard of care for cervical esophageal cancer. There are significant differences in tumor response to chemoradiation and recurrence patterns between squamous cell cancer and adenocarcinoma of the esophagus. Multimodality therapy for esophageal cancer continues to progress, now with the widespread use of PET scanning and possible active surveillance in patients with complete clinical response to chemoradiation. As drug development and targeted therapy trials continue to expand, our understanding of tumor biology and precision medicine will continue to refine the treatment of esophageal cancer.
Identifiants
pubmed: 34048764
pii: S0039-6109(21)00018-9
doi: 10.1016/j.suc.2021.03.006
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
443-451Informations de copyright
Copyright © 2021 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Disclosure The authors have nothing to disclose.